{"id":44046,"date":"2024-07-24T07:50:47","date_gmt":"2024-07-24T06:50:47","guid":{"rendered":"https:\/\/wames.org.uk\/cms-english\/?p=44046"},"modified":"2024-07-24T07:52:05","modified_gmt":"2024-07-24T06:52:05","slug":"research-marginal-differences-found-between-me-cfs-lc","status":"publish","type":"post","link":"https:\/\/wames.org.uk\/cms-english\/research-marginal-differences-found-between-me-cfs-lc\/","title":{"rendered":"Research: Marginal differences found between ME\/CFS &#038; LC"},"content":{"rendered":"<h2><strong>ME\/CFS &amp; Long COVID patients have similar symptoms &amp; quality of life<\/strong><\/h2>\n<p>&nbsp;<\/p>\n<p>This Australian study compared 61 patients with ME\/CFS with 31 patients with Long Covid (aka Post COVID-19 condition- PCC) and found few differences in symptoms between the two groups.<\/p>\n<p>They say: &#8220;this publication documents the profound and widespread illness burden experienced by pwME\/CFS and pwPCC in Australia, thereby necessitating health policy reforms that facilitate improved accessibility of necessary care and support services for Australians living with these illnesses.<\/p>\n<p>The present study observed marginal differences in illness presentation between pwPCC and pwME\/CFS, with notable similarities between the two cohorts in key symptoms typically experienced by pwME\/CFS, such as <strong>post-exertional malaise<\/strong>, <strong>neurocognitive dysfunction<\/strong> and <strong>sleep disturbances<\/strong>.&#8221;<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter wp-image-44187 size-full lazyload\" data-src=\"https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2024\/07\/MECFS-LC-Oz-study-2024.jpg?resize=800%2C572&#038;ssl=1\" alt=\"\" width=\"800\" height=\"572\" data-srcset=\"https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2024\/07\/MECFS-LC-Oz-study-2024.jpg?w=800&amp;ssl=1 800w, https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2024\/07\/MECFS-LC-Oz-study-2024.jpg?resize=300%2C215&amp;ssl=1 300w, https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2024\/07\/MECFS-LC-Oz-study-2024.jpg?resize=150%2C107&amp;ssl=1 150w, https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2024\/07\/MECFS-LC-Oz-study-2024.jpg?resize=768%2C549&amp;ssl=1 768w\" data-sizes=\"(max-width: 800px) 100vw, 800px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 800px; --smush-placeholder-aspect-ratio: 800\/572;\" \/><\/p>\n<p>Other past studies also found all pwPCC experienced post-exertional malaise though 2 had found a lower prevalence of post-exertional malaise 82.8% and 78% &#8220;Post-exertional malaise is a noteworthy component of the PCC illness presentation and should be considered in diagnostic criteria and care provision.&#8221;<\/p>\n<p>&#8220;Among the cardinal ME\/CFS symptoms, only <strong>memory loss<\/strong> was significantly more prevalent and <strong>unrefreshed sleep<\/strong> significantly more frequent among pwME\/CFS than pwPCC in the present study.&#8221;<\/p>\n<p>The few remaining significant differences in symptom presentation between the cohorts included a higher prevalence of <strong>muscle weakness<\/strong>, <strong>lymphadenopathy and nause<\/strong>a, greater severity of <strong>light-headedness<\/strong>, and reduced frequency of <strong>heart palpitation<\/strong>s among pwME\/CFS. However, the existing literature is incongruous regarding the presentation of such symptoms among pwME\/CFS and pwPCC .<\/p>\n<p>Additionally, comparisons of illness presentation have largely focused on symptom prevalence and few investigations have compared symptom frequency and severity among these two illness cohorts.&#8221;<\/p>\n<p>Hence, fulfilment of ME\/CFS criteria following acute COVID-19 illness may be an indicator of illness trajectory and a means of identifying pwPCC at risk of long-term illness.<\/p>\n<p>&#8220;The findings of the present study underscore the risk of developing permanent chronic illness and disability following acute COVID-19 illness and foreground the potential role of ME\/CFS in the illness progression and diagnosis of PCC.<\/p>\n<p>This also has important ramifications for estimating the future healthcare burdens of post-COVID-19 sequelae (as over 90% of people with ME\/CFS experience life-long illness and emphasises the importance of reducing SARS-CoV-2 transmission.&#8221;<\/p>\n<p>&#8220;Findings exemplify the physically disabling nature of ME\/CFS and PCC, which must be considered in the provision of care for people with these illnesses&#8230; Importantly, the impacts on daily activities observed in this study emphasise the need for integrated approaches across the healthcare, disability and social support sectors for pwME\/CFS and pwPCC in Australia.&#8221;<\/p>\n<h3><strong>Read the full paper:<\/strong><\/h3>\n<p><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s11136-024-03710-3\" target=\"_blank\" rel=\"noopener\">Illness presentation and quality of life in myalgic encephalomyelitis\/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study\u00a0<\/a>, by Breanna Weigel, Natalie Eaton-Fitch, Kiran Thapaliya, Sonya Marshall-Gradisnik<span style=\"text-decoration: underline;\"> in<\/span> <em>Qual Life Res.<\/em> 2024 Jul 3 [doi: 10.1007\/s11136-024-03710-3]<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ME\/CFS &amp; Long COVID patients have similar symptoms &amp; quality of life &nbsp; This Australian study compared 61 patients with ME\/CFS with 31 patients with Long Covid (aka Post COVID-19 condition- PCC) and found few differences in symptoms between the &hellip; <a href=\"https:\/\/wames.org.uk\/cms-english\/research-marginal-differences-found-between-me-cfs-lc\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-44046","post","type-post","status-publish","format-standard","hentry","category-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p5qkYK-bsq","_links":{"self":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/44046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/comments?post=44046"}],"version-history":[{"count":5,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/44046\/revisions"}],"predecessor-version":[{"id":44196,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/44046\/revisions\/44196"}],"wp:attachment":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/media?parent=44046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/categories?post=44046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/tags?post=44046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}